Big move for biotechs isn't pleasant.
He bought weak big-caps in 1939. You can do the same today with oil.
Price is breaking out above the $32 mark, with little resistance until we hit the $35 area.
The direction of the U.S. dollar and the price of crude will tip the scales on APC.
Investors looking for an oil rebound might find Polaris a better play than owning oil companies directly.
Prices appear poised to roll over.
Momentum in the name is weakening on its daily chart.
We look for PXD to correct into the $150 to $135 area in the third quarter.
Buy this E&P on any pullback to around $35.
Twitter buzz centered on energy as OPEC ministers convened to discuss potentially capping production among member nations.

Columnist Conversations

WMT held in very well during the 'Brexit' selling wave (
The VIX has been hammered here, and we want to pick up some volatility BOUGHT VXX JULY 13 CALL AT 1.23
The S&P continues to clear key upside hurdles after holding the symmetry support at the lows.  Here is on...
Market adding to gains and threatening to make it three days in a row of gains after sharp falls Friday & ...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.